Inpure Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-12-2024
- Paid Up Capital ₹ 0.10 M
as on 04-12-2024
- Company Age 5 Year, 7 Days
- Last Filing with ROC 31 Mar 2023
- Revenue -91.34%
(FY 2022)
- Profit -1553.04%
(FY 2022)
- Ebitda -287.03%
(FY 2022)
- Net Worth -123.77%
(FY 2022)
- Total Assets 78.26%
(FY 2022)
About Inpure Pharmaceuticals
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Hardik Madaan and Taruna Sabikhi serve as directors at the Company.
- CIN/LLPIN
U24304DL2020PTC360118
- Company No.
360118
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jan 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Inpure Pharmaceuticals Private Limited offer?
Inpure Pharmaceuticals Private Limited offers a wide range of products and services, including Fertilizers and Soil Additives, Sulfur Fertilizers, Potassic Fertilizers.
Who are the key members and board of directors at Inpure Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Taruna Sabikhi  | Director | 10-Jan-2020 | Current |
| Hardik Madaan | Director | 10-Jan-2020 | Current |
Financial Performance of Inpure Pharmaceuticals.
Inpure Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 91.34% decrease. The company also saw a substantial fall in profitability, with a 1553.04% decrease in profit. The company's net worth observed a substantial decline by a decrease of 123.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Inpure Pharmaceuticals?
Unlock access to Inpure Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Inpure Pharmaceuticals?
Unlock and access historical data on people associated with Inpure Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inpure Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inpure Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
